Skip to main content

Table 3 Indicating the results for Bayesian log-normal AFT model using INLA method

From: Assessing survival time of heart failure patients: using Bayesian approach

Covariates Categories Pmean Sd Median Credible Interval Mode Kld
  Intercept 4.953 0.221 4.945 [4.541, 5.409]* 4.929 0
Age  ≤ 49–65 Ref      
49–65 −0.258 0.115 −0.256 [−0.488, −0.036]* −0.253 0
 ≥ 65 −0.336 0.110 −0.335 [−0.557, −0.125]* −0.331 0
Hypertension No Ref      
Yes −0.301 0.076 −0.300 [−0.452, −0.153]* −0.299 0
CKD No Ref      
Yes −0.389 0.075 −0.388 [−0.537, −0.244]* −0.387 0
Etiology of Heart failure IHD Ref      
RVHD −0.302 0.116 −0.302 [−0.533, −0.076]* −0.300 0
Cardiomyopathy −0.158 0.113 −0.158 [−0.382, 0.063] −0.157 0
HDD −0.258 0.115 −0.257 [−0.486, −0.035]* −0.255 0
Others −0.381 0.160 −0.381 [−0.693, −0.066]* −0.382 0
Smoking cigarette No Ref      
Yes −0.156 0.073 −0.155 [−0.300, −0.014]* −0.154 0
Stages of Heart failure I Ref      
II −0.400 0.190 −0.397 [−0.782, −0.038]* −0.389 0
III −0.423 0.176 −0.419 [−0.781, −0.090]* −0.410 0
IV −0.506 0.173 −0.501 [−0.857, −0.180]* −0.492 0
Diabetes mellitus Not Ref      
Type I −0.232 0.10 0.231 [−0.431, −0.036]* −0.230 0
Type II −0.422 0.086 −0.421 [−0.593, −0.255]* −0.419 0
Anemia No Ref      
Yes −0.154 0.072 −0.153 [−0.298, −0.013]* −0.152 0
Tau parameter For log-normal 4.30 0.497 4.28 [3.38, 5.33]* 4.24
  1. Source: JUMC, Jimma, Ethiopia; from first January 2016 to first January 2019
  2. *Is indicated statistically significant. Pmean, Posterior Mean; CKD, Chronic kidney disease; IHD, Ischemic heart disease; RVHD, Rheumatic valvular heart disease; HHD, Hypertensive heart disease, Sd, Standard deviation, KLD, Kullback–Leibler Divergence